Catalio Capital Management, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001958125
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 39 positions · Total reported value $532.10M · Top-10 concentration 56.7% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 60.8% · 10 new · 9 cut · 12 exited
Active Share (vs S&P 500): 98.6% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +22.7% · vs SPY +7.9% · Prev Value $478.70M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, Catalio Capital Management, LP disclosed 39 equity positions with a combined reported value of $532.10M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were AVLN ($55.17M), JNJ ($35.29M), GILD ($34.02M). By sector, the heaviest allocations are Health Care 98.3%, Other 1.7%. Versus the prior quarter, allocation shifted toward Health Care (+8.9pp) and away from Other (-8.9pp).
Versus the prior quarter, Catalio Capital Management, LP opened 10 new positions, trimmed 9 and fully exited 12, a turnover rate of 60.8% of positions. The portfolio's overlap with the prior quarter was 57% of names.
The largest new positions opened in Q2 2026 were AVLN ($55.17M), JNJ ($35.29M), PBLS ($22.55M).
Of the 12 positions fully exited versus the prior quarter, the largest were TERN ($21.56M), SLNO ($19.35M), BSX ($18.78M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- TERN TERNS PHARMACEUTICALS INC · prev qtr: $21.56M
- SLNO SOLENO THERAPEUTICS INC · prev qtr: $19.35M
- BSX BOSTON SCIENTIFIC CORP COM · prev qtr: $18.78M
- CYTK CYTOKINETICS INC · prev qtr: $14.20M
- ADPT ADAPTIVE BIOTECHNOLOGIES · prev qtr: $10.03M
- KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $8.59M
- QURE UNIQURE NV · prev qtr: $8.03M
- ABVX ABIVAX SA · prev qtr: $5.25M
Insider Transactions (Form 4)
Latest Catalio Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-16 | Conversion | Iambic Therapeutics, Inc. | 742,546 | — | SEC filing |
| 2026-10-16 | Conversion | Iambic Therapeutics, Inc. | 1,458,290 | — | SEC filing |
| 2026-10-16 | Conversion | Iambic Therapeutics, Inc. | 1,995,749 | — | SEC filing |
Fund Profile
Catalio Capital Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $532.10M. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-121976 (status: Approved), registered 2021-07-30
- Regulatory AUM (Form ADV): $1.93B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 78%, pooled investment vehicles 13%
- Manages 23 private funds, of which 1 hedge funds
Portfolio Structure
- 39 positions · $532.10M reported value (Q2 2026)
- Top 10 holdings = 56.7% of reported value
- Largest position: AVLN (AVALYN PHARMA INC) at 10.4%
- Average position size: $13.64M
Sector Tilt
- Health Care 98.3%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 10 new, 15 added, 9 reduced, 12 exited
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.68M | $55.17M | 10.37% | New | |
| 2 |
|
138.95K | $35.29M | 6.63% | New | |
| 3 |
|
269.31K | $34.02M | 6.39% | Add | |
| 4 |
|
455.04K | $33.89M | 6.37% | Add | |
| 5 |
|
1.22M | $26.58M | 4.99% | Add | |
| 6 |
|
562.67K | $26.47M | 4.97% | Reduce | |
| 7 |
|
412.96K | $23.79M | 4.47% | Reduce | |
| 8 |
|
824.04K | $22.55M | 4.24% | New | |
| 9 |
|
82.18K | $22.31M | 4.19% | Add | |
| 10 |
|
191.63K | $21.72M | 4.08% | Add | |
| 11 |
|
536.15K | $17.96M | 3.37% | Add | |
| 12 |
|
648.72K | $17.50M | 3.29% | Add | |
| 13 |
|
583.05K | $17.11M | 3.21% | Add | |
| 14 |
|
1.08M | $16.15M | 3.04% | Add | |
| 15 |
|
276.55K | $14.84M | 2.79% | Add | |
| 16 |
|
106.80K | $13.09M | 2.46% | New | |
| 17 |
|
159.38K | $11.66M | 2.19% | Add | |
| 18 |
|
124.78K | $11.29M | 2.12% | Reduce | |
| 19 |
|
43.18K | $10.57M | 1.99% | New | |
| 20 |
|
316.25K | $10.56M | 1.99% | Reduce | |
| 21 |
|
468.75K | $10.33M | 1.94% | New | |
| 22 |
|
940.86K | $9.19M | 1.73% | Add | |
| 23 |
|
457.84K | $8.57M | 1.61% | New | |
| 24 |
|
31.76K | $8.47M | 1.59% | Reduce | |
| 25 |
|
312.50K | $7.45M | 1.40% | New | |
| 26 |
|
1.70M | $6.68M | 1.25% | Add | |
| 27 |
|
471.25K | $6.27M | 1.18% | New | |
| 28 |
|
45.86K | $5.64M | 1.06% | Reduce | |
| 29 |
|
244.93K | $5.44M | 1.02% | Reduce | |
| 30 |
|
6.17M | $4.90M | 0.92% | Add | |
| 31 |
|
148.04K | $4.70M | 0.88% | Add | |
| 32 |
|
32.94K | $3.21M | 0.60% | Reduce | |
| 33 |
|
318.41K | $2.43M | 0.46% | New | |
| 34 |
|
520.15K | $1.99M | 0.37% | Reduce | |
| 35 |
|
1.32M | $1.78M | 0.34% | Hold | |
| 36 |
|
196.86K | $1.04M | 0.20% | Hold | |
| 37 |
|
528.99K | $629.50K | 0.12% | Hold | |
| 38 |
|
118.28K | $510.96K | 0.10% | Hold | |
| 39 |
|
14.72K | $367.95K | 0.07% | Hold | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 50% R 50% F1 50% (modelled on 2026-Q1; 5/10 hit)
Historical Backtest (5 quarters)
Avg precision 66% · recall 66% · F1 66% · avg rank error 4.0 · Top-10 turnover 35%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2025-Q2 | 70% | 70% | 70% | BDX · BBIO · EW · SWTX · ASND · VCYT · CYTK · SNDX · LLY · ISRG | LLY · BBIO · SLNO · ASND · ISRG · EW · GILD · BSX · CYTK · SNDX |
| 2025-Q3 | 80% | 80% | 80% | LLY · BBIO · SLNO · ISRG · EW · ASND · BSX · GILD · SNDX · CYTK | LLY · ABBV · BBIO · ISRG · ASND · SLNO · DNTH · BSX · SNDX · CYTK |
| 2025-Q4 | 60% | 60% | 60% | LLY · ABBV · ISRG · SLNO · BBIO · BSX · ASND · NTRA · DNTH · SNDX | GILD · BMY · BSX · BBIO · LLY · DNTH · ASND · SNDX · JNJ · REGN |
| 2026-Q1 | 70% | 70% | 70% | BMY · GILD · BSX · BBIO · LLY · DNTH · REGN · JNJ · ASND · SNDX | DNTH · BBIO · ASND · BMY · SNDX · GILD · TERN · DFTX · SLNO · BSX |
| 2026-Q2 ★ | 50% | 50% | 50% | DNTH · BBIO · ASND · BMY · TERN · SNDX · GILD · SLNO · RARE · DFTX | AVLN · JNJ · GILD · BBIO · SNDX · DFTX · BMY · PBLS · NTRA · INCY |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did Catalio Capital Management, LP buy in 2026-Q2?
In its 2026-Q2 13F filing, Catalio Capital Management, LP reported 39 equity positions worth $532.10M in aggregate; its largest disclosed positions were AVLN ($55.17M), JNJ ($35.29M), GILD ($34.02M).
How large is Catalio Capital Management, LP's portfolio?
Catalio Capital Management, LP reported $532.10M of long equity holdings across 39 positions as of 2026-Q2. Top-10 holdings account for 56.7% of reported value.
What is Catalio Capital Management, LP's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.